References
Belongia EA, Hedberg CW, Gleich GJ et al (1990) An investigation of the cause of the eosinophilia-myalgia syndrome associated with tryptophan use.N Engl J Med 323: 357–365.
Foster AC, Kemp JA (1989) Glycine maintains excitement.Nature 338: 377–378.
Huettner JE (1991) Competitive antagonism of glycine at theN-methyl-d-aspartate (NMDA) receptor.Biochem Pharmacol 41: 9–16.
Johnson JW, Ascher P (1987) Glycine potentiates the NMDA response in cultured mouse brain neurons.Nature 325: 529–531.
Moroni F, Russi, P, Lombardi G, Beni M Carla V (1988) Presence of kynurenic acid in the mammalian brain.J Neurochem 51: 177–180.
Ohya Y, Ochi N, Mizutani N, Hayakawa C, Watanabe K (1991) Nonketotic hyperglycinemia: Treatment with NMDA antagonist and consideration of neuropathogenesis.Pediatr Neurol 7: 65–68.
Robinson MB, Anderson KD, Koerner JF (1984) Kynurenic acid as an antagonist of hippocampal excitatory transmission.Brain Res 309: 119–126.
Russi P, Carla V, Moroni F (1989) Indolepyruvic acid administration increases the brain content of kynurenic acid. Is this a new avenue to modulate excitatory amino acid receptors in vivo?Biochem Pharmacol 38: 2405–2409.
Wolff JA, Kulovich S, Yu AL, Qiao C-N, Nyhan WL (1986) The effectiveness of benzoate in the management of seizures in nonketotic hyperglycinemia.Am J Dis Child 140: 596–602.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Inoue, F., Matsuo, S., Yoshioka, H. et al. Tryptophan therapy for non-ketotic hyperglycinaemia. J Inherit Metab Dis 15, 399–401 (1992). https://doi.org/10.1007/BF02435987
Issue Date:
DOI: https://doi.org/10.1007/BF02435987